Kemmer N - Search Results

1

Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study.

Alsina AE, Makris A, Nenos V, Sucre E, Arrobas J, Franco E, Kemmer N. Alsina AE, et al. Among authors: kemmer n. Am Surg. 2014 Jul;80(7):680-4. doi: 10.1177/000313481408000723. Am Surg. 2014. PMID: 24987900

2

Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma.

Mathur A, Franco ES, Leone JP, Osman-Mohamed H, Rojas H, Kemmer N, Neff GW, Rosemurgy AS, Alsina AE. Mathur A, et al. Among authors: kemmer n. HPB (Oxford). 2013 Jul;15(7):504-10. doi: 10.1111/j.1477-2574.2012.00602.x. Epub 2012 Nov 19. HPB (Oxford). 2013. PMID: 23750492 Free PMC article.

3

Is Fulminant Hepatic Failure the Nemesis for Liver Transplant Centers? A Two Decade Psychosocial and Long-Term Outcome Study.

Alsina A, Alsina A, Athienitis A, Buggs J, Aslam S, Kemmer N. Alsina A, et al. Among authors: kemmer n. Am Surg. 2018 Jul 1;84(7):1197-1203. Am Surg. 2018. PMID: 30064588

4

Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma.

Alsina AE, Franco E, Nakshabandi A, Albers C, Kemmer N, Berry AC, Finan J. Alsina AE, et al. Among authors: kemmer n. ACG Case Rep J. 2016 Aug 17;3(4):e106. doi: 10.14309/crj.2016.79. eCollection 2016 Aug. ACG Case Rep J. 2016. PMID: 27807568 Free PMC article.

5

Orthotopic liver transplantation in a multiethnic population: role of spatial accessibility.

Kemmer N, Alsina A, Neff GW. Kemmer N, et al. Transplant Proc. 2011 Dec;43(10):3780-2. doi: 10.1016/j.transproceed.2011.09.041. Transplant Proc. 2011. PMID: 22172846

6

Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation.

Kemmer N, Neff GW, Franco E, Osman-Mohammed H, Leone J, Parkinson E, Cece E, Alsina A. Kemmer N, et al. Transplantation. 2013 Nov 27;96(10):860-2. doi: 10.1097/01.TP.0000436723.59879.01. Transplantation. 2013. PMID: 24247899

7

Outcomes of abdominal surgeries in cirrhotic patients performed by liver transplant surgeons: Are these safe?

Alsina AE, Athienitis A, Nakshabandi A, Claudio RE, Aslam S, Arroyo J, Hillenberg I, Mallorga A, Lahoti M, Kemmer N. Alsina AE, et al. Among authors: kemmer n. Am J Surg. 2018 Sep;216(3):518-523. doi: 10.1016/j.amjsurg.2018.05.006. Epub 2018 May 12. Am J Surg. 2018. PMID: 29803498

8

Social determinants of orthotopic liver transplantation candidacy: role of patient-related factors.

Kemmer N, Alsina A, Neff GW. Kemmer N, et al. Transplant Proc. 2011 Dec;43(10):3769-72. doi: 10.1016/j.transproceed.2011.08.076. Transplant Proc. 2011. PMID: 22172844

9

Update on the management of cirrhosis - focus on cost-effective preventative strategies.

Neff GW, Kemmer N, Duncan C, Alsina A. Neff GW, et al. Among authors: kemmer n. Clinicoecon Outcomes Res. 2013 Apr 12;5:143-52. doi: 10.2147/CEOR.S30675. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23626470 Free PMC article.

10

Malleable Transplant Criteria: At What Cost?

Alsina A, Apple R, Kemmer N, Orlowski JP. Alsina A, et al. Among authors: kemmer n. Narrat Inq Bioeth. 2019;9(1):77-82. doi: 10.1353/nib.2019.0020. Narrat Inq Bioeth. 2019. PMID: 31031293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters